Search Within

Ross Levine

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (386)
  2. Meeting Abstract (343)
  3. Editorial (14)
  4. Review (13)
  5. Research Letter (10)
  6. Book Section (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Whole (1)
Groups
  1. Adult Leukemia (774)
  2. Center for Hematologic Malignancies (774)
  3. Department of Medicine (774)
  4. Executive Committee, Center for Hematologic Malignancies (774)
  5. GSK Faculty (774)
  6. Hematologic Malignancies, Division of (774)

More Groups

People
  1. Omar Abdel-Wahab (166)
  2. Martin Tallman (131)
  3. Raajit Rampal (87)
  4. Eytan Stein (69)
  5. Maria Arcila (60)
  6. Jay Patel (52)

More People

Years
  1. 2025 (5)
  2. 2024 (32)
  3. 2023 (46)
  4. 2022 (41)
  5. 2021 (44)
  6. 2020 (58)

More Years

Publications
  1. Blood (289)
  2. Leukemia (34)
  3. Cancer Research (27)
  4. Haematologica (24)
  5. Blood Advances (21)
  6. Cancer Cell (21)

More Publications

Publishers
  1. American Society of Hematology (312)
  2. Nature Publishing Group (107)
  3. American Association for Cancer Research (67)
  4. Cell Press (47)
  5. Ferrata Storti Foundation (24)
  6. American Society of Clinical Oncology (22)

More Publishers

Results (774)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
    Journal Article

    Ntziachristos, P.; Tsirigos, A.; Vlierberghe, P. V.; Nedjic, J.; Trimarchi, T.; Flaherty, M. S.; Ferres-Marco, D.; Da Ros, V.; Tang, Z.; Siegle, J.; more...
    Nature Medicine (2012)

    Fulltext@MSK | Save
  • Genetics of the myeloproliferative neoplasms
    Book Section

    Abdel-Wahab, O.; Levine, R. L.
    In Verstovsek, S.; Tefferi, A. (Eds.) Myeloproliferative Neoplasms: Biology and Therapy (2011)

    Fulltext@MSK | Save
  • Cytomorphologic and clinical features of AML with translocation (8;16) mimicking APL
    Meeting Abstract

    Jhanwar, S.; Diab, A.; Zickl, L.; Manji, G. A.; Patel, J.; Abdel-Wahab, O. I.; Jurcic, J. G.; Maslak, P. G.; Steinherz, P. G.; Paietta, E.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A mathematical methodology for determining the temporal order of pathway alterations in cancer
    Meeting Abstract

    Cheng, Y. K.; Beroukhim, R.; Levine, R. L.; Mellinghoff, I. K.; Holland, E. C.; Michor, F.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium
    Journal Article

    Tefferi, A.; Abdel-Wahab, O.; Ervantes, F. C.; Crispino, J. D.; Finazzi, G.; Girodon, F.; Gisslinger, H.; Gotlib, J.; Kiladjian, J. J.; Levine, R. L.; more...
    Blood Cancer Journal (2011)

    Fulltext@MSK | Save
  • Induction of megakaryocyte polyploidization in combination with JAK inhibition as a novel therapeutic strategy for myeloproliferative neoplasms
    Meeting Abstract

    Wen, Q. J.; Goldenson, B.; Malinge, S.; Koppikar, P.; Levine, R. L.; Tefferi, A.; Crispino, J.
    Blood (2011)

    Fulltext@MSK | Save
  • HSP90 inhibition targets JAK2 and is highly effective in CRLF2-rearranged acute lymphoblastic leukemia
    Meeting Abstract

    Weigert, O.; Bird, L.; Kopp, N.; Lane, A. A.; Chapuy, B.; van Bodegom, D.; Marubayashi, S.; Yoda, A.; Romanet, V.; Murakami, M.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Mutational analysis of therapy-related MDS/AML
    Meeting Abstract

    Shih, A. H.; Chung, S. S.; Dolezal, E. K.; Zhang, S. J.; Abdel-Wahab, O.; Park, C. Y.; Nimer, S. D.; Levine, R. L.; Klimek, V. M.
    Blood (2011)

    Fulltext@MSK | Save
  • Genetic and functional investigation of germline JAK2 alleles that predispose to myeloproliferative neoplasms
    Meeting Abstract

    Schram, A. M.; Xu, X.; Kilpivaara, O.; Mukherjee, S.; Viny, A. D.; Guryanova, O.; Klein, R. J.; Levine, R. L.
    Blood (2011)

    Fulltext@MSK | Save
  • Dynamics of mutant alleles in patients with advanced essential thrombocythernia (ET) or polycythemia (PV) during pegylated interferon-alfa-2A (PEG-IFN-alpha-2A; pegasys) therapy
    Meeting Abstract

    Quintas-Cardama, A.; Abdel-Wahab, O.; Levine, R. L.; Manshouri, T.; Roupie, A. L.; Kantarjian, H. M.; Verstovsek, S.
    Blood (2011)

    Fulltext@MSK | Save